Registering for more than one person? A TMA login is required for each person you register. Need help? Contact the TMA Knowledge Center at (800) 880-7955.
You must select a location to proceed.
Yes
No
There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.
Although cancer risks from alcohol consumption are often overlooked, alcohol use is directly attributed to about 4.8% of all newly diagnosed breast and assorted cancers annually. In Texas, this translates to about 5,000 new cancer cases and 1,000 cancer deaths. Play this webinar to better understand the biological and biochemical mechanisms of alcohol risk and alcohol-related cancer morbidity and mortality.
Program Highlights
Epidemiological evidence for the association between alcohol use and cancers
Current dietary guidelines for alcohol intake
Alcohol and its impact on cancer treatment and outcomes
Learning Objectives Upon completion of this program, participants should be able to:
Discuss the biological and biochemical mechanisms of alcohol consumption and cancer risk, and
Describe dietary guidelines for alcohol consumption.
Competencies This program addresses the following desirable physician attributes: medical knowledge and provide patient-centered care.
Return Policy No refunds or exchanges will be processed for this program.
0.5 AMA PRA Category 1 Credits™ (Enduring) The Texas Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Texas Medical Association designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
On select courses, the Texas Medical Association requires physician to complete 70-percent of the test questions correctly to receive credit for this course.
Adding Registration, Please wait...
